References
- Koester G., Tarnower A., Levisohn D., Burgdorf W. Bullous pyoderma gangrenosum. Journal of the American Academy of Dermatology 1993; 29: 875–878
- Schmitt E. C., Pigatto P. D., Boneschi V., Bubola D., Finzi A. F. Pyodema gangrenosum treated with low-dose cyclosporin. British Journal of Dermatology 1993; 128: 230–231
- Ross H. J., Moy L. A., Kaplan R., Figlin R. A. Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment. Cancer 1991; 68: 441–443
- Dreicer R., Schiller J. H., Carbone P. P. Granulocyte-macrophage colony-stimulating factor and vas-culitis. Annals of Internal Medicine 1989; 111: 91–92
- Johnson M. M. L., Grimwood C. R. E. Leukocyte colony-stimulating factors. A review of associated neu-trophilic dermatoses and vasculitides. Archives of Dermatology 1994; 130: 77–81
- Park J. W., Mehrotra B., Barnett B. O., Baron A. D., Venook A. P. The Sweet syndrome during therapy with granulocyte colony-stimulating factor. Annals of Internal Medicine 1992; 116: 996–998
- Perrot J. L., Benoit F., Segault D., Jaubert J., Guyotat D., Claudy A. Pyodenna gangrenosum aggrave par administration de GM-CSF. Ann. Dermatol. Venereol. 1992; 119: 846–848
- Hellstrom-Lindber E., Negrin R., Stein R., Krantz S., Wardiman J., ÖSt Å., Lindberg G., Greenberg P. Efficacy of G-CSF and EPO on the anemia in patients with myelodysplastic syndromes. Blood 1995; 86, suppl. 1, Abstract no 1340.
- Curley R. K., Macfarlane A. W., Vickers C. F. H. Pyodema gangrenosum treated with cyclosporin A. British Journal of Dermatology 1985; 113: 601–604